Canada has an agreement with AZ to receive 20 million doses. The approval to Verity Pharmaceuticals Inc./Serum Institute of India product h...

Israeli studies have found the Pfizer vaccine to be 95 percent effective one week after a second jab, while the Lancet report focused on mo...

A phase I/II trial conducted by University of Witwatersrand and Oxford University on 2,000 volunteers with a median age of 31 years found t...

The Co-WIN app announced by the government will be central to the registration process.

The company is ready to start rolling out supplies of its Covishield vaccine in a week’s time, Poonawalla said. SII is waiting for a formal...

The SEC was called soon after the UK regulator authorised Oxford University/AstraZeneca’s Covid-19 vaccine for use. The approval by UK regu...

The subject expert committee in India is awaiting a nod from the UK's regulator to sign off on the marketing authorisation for SII to deliv...

“India’s drug regulator is in touch with UK drug authorities on the approval progress of the AZ/Oxford vaccine trial,” Vinod Paul, head of ...

Companies such as Zydus Cadila, Bharat Biotech, Dr Reddys-Gamaleya Institute, Serum Institute-AstraZeneca and Gennova are expected to submi...

The US Food and Drug Administration has released its findings on the Pfizer/BioNtech efficacy data where it suggested that the vaccine at a...

“ChAdOx1 nCoV-19 has an acceptable safety profile and has been found to be efficacious against symptomatic Covid-19 in this interim analysi...

The company announced that in a small subgroup of the trial participants the vaccine showed better efficacy when administered a half dose f...

While most experts are confident that India will get a vaccine, their concern is how the country will scale up to vaccinate its 1.3 billion...

AZ on Wednesday morning said that it was temporarily halting the trial of the vaccine candidate after one of the participants developed "un...

While the vaccine could be available at USD 3-6 (Rs 225 to Rs 550) per dose, herd immunity might be two years away due to implementation ch...

According to the Clinical Trial Registry India, the scientific title of the study says that phase 2/3 clinical trial will be observer-blind...

As part of the agreement SII will also get upfront capital of $150 mn via the Bill and Melinda Gates Foundation to help the company increas...